Shares of Somaxon Pharmaceuticals (SOMX) are +31.2% premarket after the company announced a...


Shares of Somaxon Pharmaceuticals (SOMX) are +31.2% premarket after the company announced a co-promotion pact with Procter & Gamble (PG) to market its insomnia drug, Silenor. PG -0.3%. (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs